|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 231.80 EUR | -1.32% |
|
-8.23% | -1.36% |
| 14/07 | Where would AI lead Pharma in the long run? |  |
| 13/07 | Antengene Receives $60 Million Milestone in UCB Licensing Deal | MT |
| Market Cap | 4.49TCr 5.13TCr 4.14TCr 3.8TCr 7.21TCr 4,93800Cr 7.33TCr 49TCr 19TCr 2,41400Cr 19TCr 19TCr 8,31900Cr | P/E 2026 * |
25.3x | P/E 2027 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.46TCr 5.1TCr 4.11TCr 3.78TCr 7.17TCr 4,90800Cr 7.29TCr 49TCr 19TCr 2,39900Cr 19TCr 19TCr 8,26900Cr | EV / Sales 2026 * |
5.22x | EV / Sales 2027 * | 4.42x |
| Free-Float |
61.59% | Yield 2026 * |
0.62% | Yield 2027 * | 0.64% |
Last Transcript: UCB
| 1 day | -1.32% | ||
| 1 week | -8.23% | ||
| Current month | -12.43% | ||
| 1 month | -12.36% | ||
| 3 months | -14.05% | ||
| 6 months | -10.85% | ||
| Current year | -1.36% |
| 1 week | 231.8 |  | 249.1 |
| 1 month | 231.8 | | 265.1 |
| Current year | 223 | | 285.4 |
| 1 year | 171.55 | | 285.4 |
| 3 years | 65.68 | | 285.4 |
| 5 years | 65.68 | | 285.4 |
| 10 years | 55.45 | | 285.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 01/01/2015 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 01/07/2020 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 01/01/2012 | |
| Director/Board Member | 67 | 01/01/2015 | |
| Director/Board Member | 56 | 24/04/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.32% | -8.23% | - | - | 5.13TCr | |
| +1.27% | +0.24% | +21.26% | -7.53% | 6.76TCr | |
| +1.10% | +38.30% | +38.30% | +38.30% | 4.3TCr | |
| +0.91% | -2.09% | -50.33% | -52.51% | 4.08TCr | |
| +2.76% | -1.56% | +54.70% | -29.29% | 2.91TCr | |
| +1.25% | -7.48% | +116.21% | -43.73% | 2.71TCr | |
| +0.18% | -1.85% | +68.63% | +86.35% | 2.3TCr | |
| -2.63% | +9.44% | +9.63% | +200.00% | 2.16TCr | |
| -1.70% | +5.53% | +76.00% | +353.68% | 1.62TCr | |
| +0.44% | -3.68% | +55.00% | +124.19% | 1.64TCr | |
| Average | +0.23% | +0.47% | +43.27% | +74.38% | 3.16TCr | |
| Weighted average by Cap. | +0.43% | +0.33% | +34.03% | +38.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 853.89Cr 976.65Cr 787.7Cr 724.09Cr 1.37TCr 94TCr 1.4TCr 9.4TCr 3.69TCr 46TCr 3.67TCr 3.59TCr 1,58300Cr | 963.67Cr 1.1TCr 888.97Cr 817.19Cr 1.55TCr 1,06100Cr 1.57TCr 11TCr 4.16TCr 52TCr 4.14TCr 4.05TCr 1,78700Cr |
| Net income | 176.54Cr 201.92Cr 162.85Cr 149.7Cr 283.65Cr 19TCr 288.5Cr 1.94TCr 762.84Cr 9.5TCr 758.28Cr 741.66Cr 33TCr | 227.36Cr 260.05Cr 209.74Cr 192.8Cr 365.31Cr 25TCr 371.56Cr 2.5TCr 982.47Cr 12TCr 976.59Cr 955.19Cr 42TCr |
| Net Debt | -27Cr -31Cr -25Cr -23Cr -44Cr -2.99TCr -44Cr -298.77Cr -117.23Cr -1.46TCr -116.53Cr -113.97Cr -5.03TCr | -231.31Cr -264.57Cr -213.38Cr -196.15Cr -371.66Cr -25TCr -378.01Cr -2.55TCr -999.54Cr -12TCr -993.56Cr -971.78Cr -43TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | €231.80 | -1.32% | 78 |
| 14/26/14 | €234.90 | -1.39% | 0 |
| 13/26/13 | €238.20 | -4.38% | 40 |
| 10/26/10 | €249.10 | -1.03% | 0 |
| 09/26/09 | €251.70 | -0.36% | 36 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
- UNC Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
